Oklahoma 2022 Regular Session

Oklahoma House Bill HB1877

Introduced
2/1/21  
Refer
2/2/21  
Report Pass
2/17/21  
Engrossed
3/2/21  
Refer
3/15/21  
Report Pass
3/29/21  
Enrolled
4/13/21  

Caption

Public health and safety; assisted living centers; long-term care facilities; antipsychotic drugs; effective date.

Companion Bills

No companion bills found.

Previously Filed As

OK HB3025

Public health and safety; Nursing Facilities Quality of Care Fee; terminating fee; effective date.

OK HB1832

Intermediate care facilities; electronic monitoring; long-term care facilities; term; intermediate care facilities; effective date.

OK HB3760

Public health and safety; Nursing Home Care Act; definition; effective date.

OK HB2801

Antipsychotic drugs; vendor drug program; Oklahoma Health Care Authority; prior authorized; disorders; prior authorization; effective date.

OK HB1987

Public health and safety; adding exception to certain defined term; effective date.

OK HB1987

Public health and safety; adding exception to certain defined term; effective date.

OK HB2119

Health care; Medicaid; nursing facilities; FMAP payments; effective date.

OK HB2656

Public health and safety; modifying exception to certain defined term; effective date.

OK HB1638

Public health and safety; death certificates; personal data; effective date.

OK SB804

Long-term care; directing promulgation of specified rules; requiring assisted living centers to establish internal quality assurance committee. Effective date.

Similar Bills

CA SB121

Budget Act of 2022: Health Omnibus.

CA AB204

Budget Act of 2022: Health Omnibus.

CA SB1317

Inmates: psychiatric medication: informed consent.

NM SB127

Professional Psychologist Act Changes

RI S2380

Prohibits prior authorization or a step therapy protocol for the prescription of a nonpreferred medication on their drug formulary used to assess or treat an enrollee's bipolar disorder, schizophrenia or schizotypal.

RI S0786

Prohibits prior authorization or a step therapy protocol for the prescription of a nonpreferred medication on their drug formulary used to assess or treat an enrollee's bipolar disorder, schizophrenia or schizotypal.

CA SB1184

Mental health: involuntary treatment: antipsychotic medication.

NJ A4853

Imposes minimum staffing requirements and certain reporting requirements on certain long-term care facilities.